Skip to main content
logo
Aceso Life Science Group Limited (HKG:0474)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1500
-0.0020 (-1.32%)
Sep 11, 2026, 3:58 PM HKT

Aceso Life Science Group Ratios and Metrics

Millions HKD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
1,3291,0543691,1741,314472
Market Cap Growth
847.37%185.60%-68.55%-10.67%178.13%-69.98%

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
3.933.12----
PS Ratio
-22.52-17.87-2.65106.706.352.78
PB Ratio
2.932.320.500.650.510.17
P/FCF Ratio
66.4452.7124.61-6.921.82
P/OCF Ratio
66.4452.7121.71-6.141.50

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
2.662.663.111.511.141.07
Debt / FCF Ratio
60.4060.40154.07-15.3811.62
Net Debt / Equity Ratio
1.941.942.821.250.900.81
Net Debt / FCF Ratio
44.1044.10139.93-47.2712.218.85
Quick Ratio
2.172.170.260.560.490.73
Current Ratio
2.282.280.280.570.700.93
Asset Turnover
---0.000.030.03
Return on Equity (ROE)
-71.62%-71.62%-50.92%-36.87%-7.70%-20.41%
Return on Assets (ROA)
-17.05%-17.05%-16.22%-14.59%-3.31%-9.59%
Return on Invested Capital (ROIC)
-8.48%-5.98%-5.34%-4.46%-1.59%-2.32%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
25.44%32.06%-205.10%-39.36%-20.09%-78.32%
FCF Yield
1.51%1.90%4.06%-4.09%14.46%54.82%
Buyback Yield / Dilution
-3.38%-3.38%1.06%0.60%1.63%-6.06%